34 Health Systems Are Walking Away From Medicare Advantage. Here Is What's Behind It.

Walking away from a major payer relationship is not something hospital systems do impulsively. The administrative burden of renegotiating, re-credentialing along with rebuilding patient referral patterns from outside a plan's network is enormous. Hospitals do it when they've concluded that staying in the network costs more than leaving it.

34 health systems have reached that conclusion in 2026.

The Medicare Advantage exit wave reflects a calculation that played out over several years of escalating prior authorization volumes, rising denial rates along with shrinking reimbursement margins from MA plans. When HCA's CFO described denial activity as “still really high” in Q1 2026 earnings after years of added resources along with technology along with targeted payer partnerships, the implication was clear. The largest health system in the country with more negotiating leverage than any individual hospital still can't solve this through relationship management alone.

For smaller regional systems, the math tipped even harder.

Why Medicare Advantage Became a Problem

Medicare Advantage penetration crossed 54% of all Medicare beneficiaries in 2026. More than half of Medicare patients now come through MA plans rather than traditional fee-for-service Medicare. That penetration level means hospitals can't simply avoid MA contracts. They have to decide which plans are worth participating in along with which aren't.

The specific issues driving exits aren't mysterious. MA plans have denial rates that run significantly higher than traditional Medicare. Prior authorization requirements have expanded to procedures that didn't require authorization five years ago. And the AI-powered claim review systems payers have deployed in 2025 along with 2026 scan claims faster than hospital billing teams can respond.

BCBSA releasing its AI upcoding analysis on September 25 along with a week that saw AI coding added to the political conversation alongside the MA contract exits is not a coincidence. The tension between hospital revenue strategies along with payer cost-control strategies is reaching a visibility threshold that historically precedes regulatory intervention.

What Exiting Medicare Advantage Contracts Actually Costs

Hospitals that exit MA contracts don't lose those patients entirely. Some patients will switch plans to follow their preferred hospital. Some will move to traditional Medicare. Some will find a different in-network provider.

The revenue impact depends entirely on how many patients follow the hospital out of the MA network along with at what reimbursement rate traditional Medicare covers the services those patients were receiving. For hospitals whose MA reimbursement had been negotiated significantly above traditional Medicare rates, exiting can actually improve per-patient margin on the patients who stay. For hospitals whose MA rates were close to traditional Medicare, the math is different.

The administrative cost reduction is real regardless. Prior authorization burden for MA patients is substantially higher than for traditional Medicare. Denial management for MA claims consumes more staff time per revenue dollar than almost any other payer category. Removing that burden from billing operations has operational value even before the reimbursement comparison.

What This Means for Revenue Cycle Strategy

The MA exit wave is forcing hospitals to make explicit decisions that most have been managing implicitly for years: which payer relationships are financially sustainable along with which aren't.

That's actually a useful discipline. Most hospital revenue cycle operations manage payer contracts as given conditions along with optimize billing operations around whatever network relationships exist. The hospitals doing explicit payer-by-payer financial analysis along with comparing the fully loaded cost of managing each payer relationship against the net revenue it generates are operating with a level of revenue clarity most billing operations don't have.

Building that visibility requires payer-specific clean claim rate data, authorization burden data along with denial rate data tracked separately rather than averaged across the payer mix. Without that granularity, a decision to exit along with renegotiate along with stay in a payer network is a judgment call rather than a financial analysis.

Our Medical Billing along with Revenue Cycle Management team helps hospitals build payer-specific revenue cycle visibility along with the billing infrastructure that makes payer decisions financially legible rather than operationally opaque.

FAQs

Why are health systems dropping Medicare Advantage contracts in 2026?

34 health systems have exited MA contracts in 2026 because of high prior authorization burdens, rising AI-powered denial rates along with reimbursement margins that don't justify the administrative cost of managing MA claims. Hospitals that have concluded the cost of staying in network exceeds the revenue benefit are exiting.

What happens to patients when hospitals exit Medicare Advantage?

Patients have several options: switch to a different MA plan that includes their hospital as in-network, switch to traditional fee-for-service Medicare along with keep their hospital, along with find a different in-network provider within their current MA plan.

Is exiting Medicare Advantage financially beneficial for hospitals?

It depends on the specific MA reimbursement rates along with the volume of patients involved along with the administrative burden of the relationship. Hospitals exiting MA contracts typically reduce prior authorization along with denial management costs while absorbing some patient volume loss.

What is the connection between MA exits along with AI claim denials?

MA plans have deployed AI-powered claim review systems that deny claims faster than hospital billing teams can respond. The increased denial rate along with prior authorization burden from AI-powered payer systems is one of the primary drivers of the MA exit wave.